Black-White Cardiovascular Disease Disparities After Target-Based Versus Personalized Benefit–Based Lipid and Blood Pressure Treatment
Background: Cardiovascular disease (CVD) remains the leading cause of black-white morbidity and mortality disparities in the United States. Objectives : We sought to compare black-white CVD morbidity and mortality if lipid and blood pressure treatments were prescribed to achieve targeted lipid and b...
Main Authors: | Sanjay Basu MD, PhD, Jeremy B. Sussman MD, MS, Rodney A. Hayward MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-08-01
|
Series: | MDM Policy & Practice |
Online Access: | https://doi.org/10.1177/2381468317725741 |
Similar Items
-
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
by: Sanjay Basu, et al.
Published: (2017-10-01) -
Correction: Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
by: Sanjay Basu, et al.
Published: (2021-09-01) -
Racial health disparities in ovarian cancer: not just black and white
by: Sanjeev K. Srivastava, et al.
Published: (2017-09-01) -
Social and economic factors and black-white disparities in cardiovascular health: A decomposition analysis
by: Nicole D. Fields, et al.
Published: (2023-09-01) -
Implications of True and Perceived Treatment Burden on Cardiovascular Medication Use
by: Jeremy B. Sussman MD, MSc, et al.
Published: (2017-10-01)